Dementia in Latin America: Paving the Way Toward a Regional Action Plan

Across Latin American and Caribbean countries (LACs), the fight against dementia faces pressing challenges, such as heterogeneity, diversity, political instability, and socioeconomic disparities. These can be addressed more effectively in a collaborative setting that fosters open exchange of knowledge. In this work, the Latin American and Caribbean Consortium on Dementia (LAC-CD) proposes an agenda for integration to deliver a Knowledge to Action Framework (KtAF). First, we summarize evidence-based strategies (epidemiology, genetics, biomarkers, clinical trials, nonpharmacological interventions, networking, and translational research) and align them to current global strategies to translate regional knowledge into transformative actions. Then we characterize key sources of complexity (genetic isolates, admixture in populations, environmental factors, and barriers to effective interventions), map them to the above challenges, and provide the basic mosaics of knowledge toward a KtAF. Finally, we describe strategies supporting the knowledge creation stage that underpins the translational impact of KtAF.

Citing Articles

Inspired by struggle: A personal journey to global precision brain health.

Ibanez A iScience. 2025; 28(2):111918.

PMID: 40028285 PMC: 11869526. DOI: 10.1016/j.isci.2025.111918.

Periodontal Indices as Predictors of Cognitive Decline: Insights from the PerioMind Colombia Cohort.

Arevalo-Caro C, Lopez D, Sanchez Milan J, Lorca C, Mulet M, Arboleda H Biomedicines. 2025; 13(1).

PMID: 39857789 PMC: 11760870. DOI: 10.3390/biomedicines13010205.

Digital Exclusion and Cognitive Function in Elderly Populations in Developing Countries: Insights Derived From 2 Longitudinal Cohort Studies.

Duan S, Chen D, Wang J, Paramboor M, Xia Z, Xu W J Med Internet Res. 2024; 26:e56636.

PMID: 39546790 PMC: 11607572. DOI: 10.2196/56636.

Gaps in biomedical research in frontotemporal dementia: A call for diversity and disparities focused research.

Nuytemans K, Franzen S, Broce I, Caramelli P, Ellajosyula R, Finger E Alzheimers Dement. 2024; 20(12):9014-9036.

PMID: 39535468 PMC: 11667558. DOI: 10.1002/alz.14312.

Use of anti-amyloid therapies for Alzheimer's disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.

Barbosa B, Resende E, Castilhos R, Borelli W, Frota N, Balthazar M Dement Neuropsychol. 2024; 18:e2024C002.

PMID: 39534440 PMC: 11556288. DOI: 10.1590/1980-5764-DN-2024-C002.

References

Grontvedt G, Lauridsen C, Berge G, White L, Salvesen O, Brathen G . The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up. J Alzheimers Dis. 2020; 74(3):829-837. PMC: 7242836. DOI: 10.3233/JAD-191227. View

Cornejo-Olivas M, Torres L, Velit-Salazar M, Inca-Martinez M, Mazzetti P, Cosentino C . Variable frequency of variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry. NPJ Parkinsons Dis. 2017; 3:19. PMC: 5460260. DOI: 10.1038/s41531-017-0020-6. View

Giraldo M, Lopera F, Siniard A, Corneveaux J, Schrauwen I, Carvajal J . Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease. Neurobiol Aging. 2013; 34(8):2077.e11-8. PMC: 3830921. DOI: 10.1016/j.neurobiolaging.2013.02.016. View

Livingston G, Sommerlad A, Orgeta V, Costafreda S, Huntley J, Ames D . Dementia prevention, intervention, and care. Lancet. 2017; 390(10113):2673-2734. DOI: 10.1016/S0140-6736(17)31363-6. View

Desikan R, Fan C, Wang Y, Schork A, Cabral H, Cupples L . Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score. PLoS Med. 2017; 14(3):e1002258. PMC: 5360219. DOI: 10.1371/journal.pmed.1002258. View

de Souza-Talarico J, de Carvalho A, Brucki S, Nitrini R, Ferretti-Rebustini R . Dementia and Cognitive Impairment Prevalence and Associated Factors in Indigenous Populations: A Systematic Review. Alzheimer Dis Assoc Disord. 2016; 30(3):281-7. DOI: 10.1097/WAD.0000000000000140. View

Arboleda-Velasquez J, Lopera F, Lopez E, Frosch M, Sepulveda-Falla D, GUTIERREZ J . C455R notch3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology. 2002; 59(2):277-9. DOI: 10.1212/wnl.59.2.277. View

Parra M, Baez S, Sedeno L, Gonzalez Campo C, Santamaria-Garcia H, Aprahamian I . Dementia in Latin America: Paving the way toward a regional action plan. Alzheimers Dement. 2021; 17(2):295-313. PMC: 7984223. DOI: 10.1002/alz.12202. View

Farina N, Suemoto C, Burton J, Oliveira D, Frost R . Perceptions of dementia amongst the general public across Latin America: a systematic review. Aging Ment Health. 2020; 25(5):787-796. DOI: 10.1080/13607863.2020.1725738. View

10.

Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

11.

Velez J, Lopera F, Sepulveda-Falla D, Patel H, Johar A, Chuah A . APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease. Mol Psychiatry. 2015; 21(7):916-24. PMC: 5414071. DOI: 10.1038/mp.2015.177. View

12.

Stern Y . Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012; 11(11):1006-12. PMC: 3507991. DOI: 10.1016/S1474-4422(12)70191-6. View

13.

de Oliveira F, Bertolucci P, Chen E, Smith M . Risk factors for age at onset of dementia due to Alzheimer's disease in a sample of patients with low mean schooling from São Paulo, Brazil. Int J Geriatr Psychiatry. 2014; 29(10):1033-9. DOI: 10.1002/gps.4094. View

14.

Tan C, Hyman B, Tan J, Hess C, Dillon W, Schellenberg G . Polygenic hazard scores in preclinical Alzheimer disease. Ann Neurol. 2017; 82(3):484-488. PMC: 5758043. DOI: 10.1002/ana.25029. View

15.

Blue E, Horimoto A, Mukherjee S, Wijsman E, Thornton T . Local ancestry at APOE modifies Alzheimer's disease risk in Caribbean Hispanics. Alzheimers Dement. 2019; 15(12):1524-1532. PMC: 6925639. DOI: 10.1016/j.jalz.2019.07.016. View

16.

Nitrini R, Barbosa M, Brucki S, Yassuda M, Caramelli P . Current trends and challenges on dementia management and research in Latin America. J Glob Health. 2020; 10(1):010362. PMC: 7303806. DOI: 10.7189/jogh.10.010362. View

17.

Gomez-Isla T, Growdon W, McNamara M, Nochlin D, Bird T, Arango J . The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain. 1999; 122 ( Pt 9):1709-19. DOI: 10.1093/brain/122.9.1709. View

18.

Alladi S, Hachinski V . World dementia: One approach does not fit all. Neurology. 2018; 91(6):264-270. DOI: 10.1212/WNL.0000000000005941. View

19.

Takada L, Bahia V, Guimaraes H, Costa T, Vale T, Rodriguez R . GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil. Alzheimer Dis Assoc Disord. 2016; 30(4):310-317. PMC: 5065374. DOI: 10.1097/WAD.0000000000000153. View

20.

Lee S, Khazenzon A, Trujillo A, Guo C, Yokoyama J, Sha S . Altered network connectivity in frontotemporal dementia with C9orf72 hexanucleotide repeat expansion. Brain. 2014; 137(Pt 11):3047-60. PMC: 4208465. DOI: 10.1093/brain/awu248. View